Calcort Tab. 6mg

Ingredient

Deflazacort (Micronized)

Content

6mg

Indication

1) rheumatoid disorders and connective tissue diseases: Maintenance therapy and treatment of acute exacerbation of psoriatic arthritis and rheumatoid arthritis, which are ineffective with general treatment, polymyalgia rheumatic, acute rheumatic fever, systemic lupus erythematosus, cranial arteritis, and Wegener’s granulomatosis
2) skin diseases: Pemphigus, bullous pemphigoid, exfoliative dermatitis, erythema multiforme, erythema nodosum, and severe psoriasis
3) allergic diseases: Bronchial asthma, which is not effective with general treatment
4) respiratory diseases: Sarcoidosis with pulmonary infiltration, extrinsic allergic alveolitis (silicosis due to organic dust), desquamative interstitial pneumonia (idiopathic pulmonary fibrosis)
5) ophthalmic diseases: Choroiditis, chorioretinitis, iritis, and iridocyciltis
6) hematopoietic system diseases: Idiopathic thrombocytopenia, hemolytic anemia, lymphatic leukemia, and lymphoma
7) gastrointestinal diseases: Ulcerative colitis and Crohn’s disease
8) liver disease: Chronic active hepatitis (autoimmune hepatitis)
9) kidney disease: Nephrotic syndrome

Celex

Ingredient

Celecoxib

Content

200mg

Indication

Celecoxib is indicated in adults for the symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.

Cleocin-T Topical soln. 1%

Ingredient

Clindamycin Phosphate

Content

1.188g/100ml (1g as Clindamycin)

Indication

Effective species: Propionibacterium acnes
Indication: Treatment of acne vulgaris

Coaprovel®Tablet 150/12.5mg, 300/12.5mg

Ingredient

[Coaprovel®Tablet 150/12.5mg]
Hydrocholorothiazide 12.5mg
Irbesartan 150mg

 

[Coaprovel®Tablet 300/12.5mg]
Hydrocholorothiazide 12.5mg
Irbesartan 300mg

Content

[Coaprovel®Tablet 150/12.5mg]
Oval film-coated tablet with a convex shape on both sides with pink color. One side is engraved with a heart shape, and the other side is marked with the number “2875”

[Coaprovel®Tablet 300/12.5mg]
Oval film-coated tablet with a convex shape on both sides with pink color. One side is engraved with a heart shape, and the other side is marked with the number “2876”

Indication

Essential hypertension
1. Patients not adequately controlled with monotherapy for hypertension
2. Initial therapy for patients, including those with moderate to severe hypertension (Stage 2), requiring combination therapy to achieve target blood pressure